IBS-Smart Blood Test
Post-Infectious Irritable Bowel Syndrome (PI-IBS)
CommercialActive
Key Facts
Indication
Post-Infectious Irritable Bowel Syndrome (PI-IBS)
Phase
Commercial
Status
Active
Company
About Gemelli Biotech
Gemelli Biotech is a commercial-stage diagnostics company focused on the high-prevalence gastrointestinal disease market. Its core assets are two direct-to-consumer/physician at-home test kits: Trio-Smart, a 3-gas breath test for Small Intestinal Bacterial Overgrowth (SIBO) and related disorders, and IBS-Smart, a blood test for post-infectious IBS. The company has established clinical validation through academic partnerships and is positioned to capitalize on the growing demand for convenient, specialized diagnostic solutions in gastroenterology.
View full company profile